Therapeutic Significance of Estrogen Receptor β Agonists in Gliomas
Gangadhara R. Sareddy(The University of Texas at San Antonio Health Science Center), Ratna K. Vadlamudi(The University of Texas at San Antonio Health Science Center), Quanguang Zhang(Augusta University), Rajeshwar R. Tekmal(The University of Texas at San Antonio Health Science Center), Darrell W. Brann(Augusta University), Andrew Brenner(The University of Texas at San Antonio Health Science Center), Vijay K. Gonugunta(The University of Texas at San Antonio Health Science Center), Binoj C. Nair(Eli Lilly (United States))
Cited by 95
Related Papers
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|835
Neurotrophic and neuroprotective actions of estrogen: Basic mechanisms and clinical implications
|Steroids|2007|638
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
|Journal of Translational Medicine|2018|540
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
|The Lancet|2021|456
NADPH oxidase in brain injury and neurodegenerative disorders
|Molecular Neurodegeneration|2017|433